Fundz

Elysium Therapeutics reported raising $2.23 Million in an amended SEC Form D filing, from an offering of $9.13 Million

PRIVATEOct 11, 2022$2.2M of $9.1M raised

Amount Raised

$2.23 Million

$2.23 Million sold, per SEC Form D (first sale Sep 27, 2022)

Round Type

Seed

AkronBiotechnologyHealthcare

Quick answer

Elysium Therapeutics raised $2.23 Million in a Seed round, dated September 27, 2022. Elysium Therapeutics is based in Akron, Ohio, United States.

How much did Elysium Therapeutics raise?
Elysium Therapeutics raised $2.23 Million in a Seed round on September 27, 2022.
What does Elysium Therapeutics do?
Elysium Therapeutics is a clinical-stage biopharmaceutical company focused on reducing suffering from severe acute pain, opioid-use disorder, and fatal opioid overdose by developing first- or best-in-class therapies..
Where is Elysium Therapeutics based and how big is it?
Elysium Therapeutics is based in Akron, Ohio, United States. Fundz records about 4 employees.
Who are the decision-makers at Elysium Therapeutics?
Fundz holds 1 contact at Elysium Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Elysium Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • LUMINOPIA raised an undisclosed amount (Seed) on November 11, 2022.
  • Curevo raised $22M on November 10, 2022.
  • Avstera Therapeutics raised an undisclosed amount (Seed) on November 9, 2022.
  • MBX Biosciences, Inc. raised $47M on November 7, 2022.
  • Statera Biopharma raised $577K (Seed) on November 1, 2022.
  • Metabolon raised $10M on November 1, 2022.

Who to call at Elysium Therapeutics, and when

A new round usually means Elysium Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elysium Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elysium Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elysium Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elysium Therapeutics

Location

57 Ogallala Rd

Akron, Ohio, United States

About

Elysium Therapeutics is a clinical-stage biopharmaceutical company focused on reducing suffering from severe acute pain, opioid-use disorder, and fatal opioid overdose by developing first- or best-in-class therapies that address the fundamental safety and abuse limitations of today’s opioids. Through its differentiated platforms—O2P™ for oral overdose protection, XpiRx™ for time-limited opioid potency, and SOOPR™ for long-acting rescue against synthetic opioids—Elysium combines strong scientific proof-of-concept using FDA-approved components, capital-efficient development supported by non-dilutive funding, robust intellectual property, and a diversified pipeline positioned to deliver multiple products in large, underserved markets within the next several years.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elysium Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlex G., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Elysium Therapeutics's next move

See what Strategic adds

Elysium Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.